INHIBITION OF 5-HT RELEASE AND METABOLISM IN THE FRONTAL-CORTEX BY DOI IS UNAFFECTED BY 5-HT2 ANTAGONISTS

被引：1
作者：
WRIGHT, IK [1 ]
MARSDEN, CA [1 ]
机构：
[1] MED CTR NOTTINGHAM,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 05期
关键词：
D O I：
10.1016/0014-2999(90)92297-V
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1949 / 1949
页数：1
相关论文
共 50 条
  • [31] A 5-HT1D RECEPTOR-LIGAND, IS NOT A 5-HT AUTORECEPTOR AGONIST OR ANTAGONIST IN THE GUINEA-PIG FRONTAL-CORTEX
    BRAMMER, NT
    DUNLOP, J
    LEVER, D
    ENNIS, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U152 - U152
  • [32] INTERACTION OF (R)-ZACOPRIDE AND (S)-ZACOPRIDE AND 5-HT3/5-HT4 RECEPTOR LIGANDS TO MODIFY EXTRACELLULAR LEVELS OF 5-HT IN THE RAT FRONTAL-CORTEX
    GE, J
    BARNES, NM
    CHENG, CHK
    COSTALL, B
    NAYLOR, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P111 - P111
  • [33] Evidence that 5-HT2 receptor agonist induced inhibtion of 5-HT cell firing is mediated by central and not peripheral 5-HT2 receptors
    Boothman, LJ
    Allers, KA
    Rasmussen, K
    Sharp, T
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U2 - U2
  • [34] A SERIES OF MORPHORINE DERIVATIVES WITH SELECTIVE 5-HT UPTAKE INHIBITION-ACTIVITY AND 5-HT2 ANTAGONIST ACTIVITY
    FUJII, M
    HAYASHIBE, S
    SUZUKI, T
    OHMORI, J
    TSUKAMOTO, S
    YATSUGI, S
    YAMAGUCHI, T
    MASE, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 64 - MEDI
  • [35] Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat
    Hervás, I
    Queiroz, CMT
    Adell, A
    Artigas, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) : 160 - 166
  • [36] Rate-independent inhibition of 5-HT release by 5-HT in the somadendritic regions of raphe neurons
    Kalsner, S
    Abdali, SA
    BRAIN RESEARCH BULLETIN, 2002, 58 (03) : 289 - 294
  • [37] BLOCKADE OF BULBOSPINAL INHIBITION BY ANTAGONISTS OF 5-HYDROXYTRYPTAMINE (5-HT)
    ANDERSON, EG
    CLINESCHMIDT, BV
    PHARMACOLOGIST, 1969, 11 (02): : 265 - +
  • [38] CHRONIC TREATMENT WITH (+/-)DOI, A PSYCHOTOMIMETIC 5-HT2 AGONIST, DOWNREGULATES 5-HT2 RECEPTORS IN RAT-BRAIN
    MCKENNA, DJ
    NAZARALI, AJ
    HIMENO, A
    SAAVEDRA, JM
    NEUROPSYCHOPHARMACOLOGY, 1989, 2 (01) : 81 - 87
  • [39] BEHAVIORAL PHARMACOLOGY OF ANTAGONISTS AT 5-HT2/5-HT1C RECEPTORS
    KOEK, W
    JACKSON, A
    COLPAERT, FC
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) : 95 - 105
  • [40] 5-HT2 ANTAGONISTS AND MINAPRINE BLOCK THE 5-HT-INDUCED INHIBITION OF DOPAMINE RELEASE FROM RAT-BRAIN STRIATAL SLICES
    MURAMATSU, M
    TAMAKIOHASHI, J
    USUKI, C
    ARAKI, H
    CHAKI, S
    AIHARA, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 153 (01) : 89 - 95
12345